THANGARAJ IMMANUEL

CIK 00012133081 companyPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001213308

Recent Transactions

50 trades

Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2012-01-03+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2012-01-03+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2011-01-03+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2011-01-03+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2009-01-02+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2009-01-02+15,000→ 15,000 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2005-09-30$0.61/sh+79,195→ 505,940 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2005-09-30$0.61/sh+79,195→ 505,940 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2005-06-30$0.63/sh+72,293→ 426,745 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2005-06-30$0.63/sh+72,293→ 426,745 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2004-12-31$0.43/sh+97,450→ 303,620 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2004-12-31$0.43/sh+97,450→ 303,620 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2004-09-30$0.43/sh+91,693→ 206,170 total
Other
ACURA PHARMACEUTICALS, INC
Common Stock
2004-09-30$0.43/sh+91,693→ 206,170 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−12,082→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−200,000→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series C-3 Preferred Stock
2004-08-13+261,830→ 15,194,393 total
Purchase
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13+59,102
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−166,666→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+172,813→ 6,756,207 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−4,889→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−133,333→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−36,747→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series A Preferred Stock
2004-08-13+311,284→ 518,806 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+584,796→ 1,755,908 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−64,694→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−38,918→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+682,260→ 1,171,112 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−333,333→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−5,000,000→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−59,102→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series C-3 Preferred Stock
2004-08-13+181,566→ 14,746,713 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−62,594→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+584,796→ 2,340,704 total
Conversion
ACURA PHARMACEUTICALS, INC
Series C-3 Preferred Stock
2004-08-13+14,363,688→ 14,363,688 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+877,193→ 3,217,897 total
Conversion
ACURA PHARMACEUTICALS, INC
Series B Preferred Stock
2004-08-13+1,524→ 488,852 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−300,000→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−7,534→ 0 total
Purchase
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13+138,841
Conversion
ACURA PHARMACEUTICALS, INC
Series C-3 Preferred Stock
2004-08-13+21,643→ 14,385,331 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−63,203→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−200,000→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−3,649,101→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series A Preferred Stock
2004-08-13+7,609→ 1,045,221 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−91,143→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−138,841→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−500,000→ 0 total
Conversion
ACURA PHARMACEUTICALS, INC
Series C-3 Preferred Stock
2004-08-13+398,854→ 15,593,247 total
Conversion
ACURA PHARMACEUTICALS, INC
5% Convertible Senior Secured Debentures due March 31, 2006
2004-08-13−200,000→ 0 total

Companies

ACURA PHARMACEUTICALS, INC
Director

Recent Filings

Address

335 BRYANT STREET

PALO ALTO, CA, 94301

View on SEC.gov